Clinical Trial Update: The Duration of Humoral Immunity and the Memory Cell Function After Vaccination With 7-valent Pneumococcal Conjugate Vaccine in CLL [Phase 4]

View source ↗

Summary

Phase 4 study assessing how durable the humoral immune response and memory cell function are after vaccination with the 7-valent pneumococcal conjugate vaccine …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• 7-valent pneumococcal conjugate vaccine (pneumococcal conjugate vaccine, 7-valent)

Snippet

Sponsor: Tampere University Hospital | Conditions: Chronic Lymphocytic Leukemia (CLL) | Phase 4 | Status: COMPLETED